Ann: Trading Halt, page-153

ABDM and jacetheace are long gone, having quit their holdings a few years ago I reckon. No doubt they were severely disappointed, like I am, that the revenue stream from P&G didn't meet their hyped up expectations. We expected the directors to have signed a much better deal with P&G than it turns out to have been - and we expected much better market penetration of our technology through P&G's products - hence why the sp surged to 12c when the first term sheet was signed back in Jan '15. I was also hoping there'd be much more development of the transdermal drug delivery possibilities of our tech rather than the focus on cosmetics - one of the reasons I first bought into OBJ.